Sillazzze
I’m not sure if it’s the same patent application that you are talking about, but with respect to Application No: 15/869,672 for Bicyclic Compounds and Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders, I see that Neuren has just paid the required issue fee for a utility patent (17/10/19). The USPTO lists the issue fee as a patent post-allowance fee.
It looks to me that whatever issues existed, this patent has just been allowed?
https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
Ann: Appendix 4C - quarterly, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.28 |
Change
-0.290(1.75%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $16.62 | $15.60 | $4.612M | 285.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 181 | $16.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.28 | 3 | 1 |
View Market Depth
| Last trade - 11.24am 11/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |